Published in Patient Prefer Adherence on February 24, 2015
Assessing patients' anticoagulation preferences for the treatment of cancer-associated thrombosis using conjoint methodology. Haematologica (2015) 0.81
Impact of a dedicated cancer-associated thrombosis service on clinical outcomes: a mixed-methods evaluation of a clinical improvement exercise. BMJ Open (2016) 0.75
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43
The epidemiology of venous thromboembolism. Circulation (2003) 6.97
Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA (2005) 6.16
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2013) 5.56
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood (2002) 3.59
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost (2007) 3.22
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost (2013) 2.24
Epidemiology and pathophysiology of cancer-associated thrombosis. Br J Cancer (2010) 1.93
Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost (2008) 1.67
The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost (2008) 1.55
Association of fatigue and psychological distress with quality of life in patients with a previous venous thromboembolic event. Thromb Haemost (2009) 1.48
Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study. Palliat Med (2005) 1.31
Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis. Lancet Oncol (2008) 1.07
The impact of venous thrombosis on quality of life. Thromb Res (2004) 1.00
The challenges of managing cancer related venous thromboembolism in the palliative care setting. Postgrad Med J (2007) 0.98
Quality of life after pulmonary embolism: validation of the PEmb-QoL Questionnaire. J Thromb Haemost (2009) 0.96
Cancer-associated thrombosis, low-molecular-weight heparin, and the patient experience: a qualitative study. Patient Prefer Adherence (2014) 0.88
Long-term psychological consequences of symptomatic pulmonary embolism: a qualitative study. BMJ Open (2014) 0.84
Quality of life after pulmonary embolism: the development of the PEmb-QoL questionnaire. J Thromb Haemost (2009) 0.81
The importance of extended thromboprophylaxis in patients undergoing major surgery for cancer. Thromb Res (2014) 0.78
The experience of patients with cancer who develop venous thromboembolism: an exploratory study. Oncol Nurs Forum (2012) 0.78